Bonadies, Nicolas; Bacher, Vera Ulrike (2019). What role can next-generation sequencing play in myelodysplastic syndrome care? Expert review of hematology, 12(6), pp. 379-382. Taylor & Francis 10.1080/17474086.2019.1613151
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
What role.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (768kB) |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Hämatologie (Erwachsene) |
UniBE Contributor: |
Bonadies, Nicolas, Bacher, Vera Ulrike |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1747-4086 |
Publisher: |
Taylor & Francis |
Language: |
English |
Submitter: |
Pierrette Durand Lüthi |
Date Deposited: |
17 Sep 2019 08:52 |
Last Modified: |
05 Dec 2022 15:30 |
Publisher DOI: |
10.1080/17474086.2019.1613151 |
PubMed ID: |
31063400 |
Uncontrolled Keywords: |
Myelodysplastic syndromes clinical management diagnosis next generation sequencing risk-stratification targeted therapies |
BORIS DOI: |
10.7892/boris.133190 |
URI: |
https://boris.unibe.ch/id/eprint/133190 |
Actions (login required)
 |
Edit item |